| Entry date | December 12, 2009 23:35 +1GMT
| | Last update | August 22, 2019 19:18 +1GMT
|
| Allergome Code | 8224
|
| Name | Hom s/Mus m Cetuximab
|
| Common Names | alpha-Gal Marker, Anti-EGFR, Cetuximab, Erbitux, IgG, IgG1, IgG1 kappa, Immunoglobulin
|
| Biological Function | Immunoglobulins, Therapeutic Antibodies, Chimeric
|
Isoforms, Variants,
Epitopes | Hom s/Mus m Cetuximab (Gal-Gal)
|
Links to Molecule
Sequences | Hom s/Mus m Cetuximab - Wiki
|
| Sources | |
Links to Source
Taxonomy | Hom s - Discover Life, Hom s - 180092 - ITIS, Hom s - 9606 - NCBI, Hom s - 9606 - UniProt, Hom s - Wikipedia, Mus m - Discover Life, Mus m - 10090 - NCBI, Mus m - 10090 - UniProt, Mus m - 180366 - ITIS, Mus m - Wikipedia
|
| Routes of Exposure | Auto-Allergen, Injection
|
Epidemiology from
Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 10.1 - Normal Control | 2011 | France | IgE | 117 | 28.200 | 20110609, Mariotte D
| | 10.2 - Normal Control, No Exposure | 2011 | France | IgE | 92 | 26.090 | 20110609, Mariotte D
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | United States | IgE | 20 | 100.000 | 20110712, van Bueren JJ
| | 6.1 - General Population | 2008 | United States | IgE | 538 | 7.060 | 20080313, Chung CH
| | 6.3 - General Population (Children) | 2011 | Ghana | IgE | 1,848 | 0.700 | 20110803, Stevens W
| | 3.2.1 - Source Sensitized (IgE) | 2009 | France | SPT | 2 | 100.000 | 20090907, Jacquenet S
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | SPT | 5 | 100.000 | 20110812, Nunez R
|
| | References | Biochemistry / Structure / Function
2012:
20120925, Toyama A
2011:
20111012, Plum M
- 20110712, van Bueren JJ
2008:
20080313, Chung CH
2007:
20070403, Qian J
2005:
20051118, Riemer AB
Molecular Biology
2008:
20080313, Chung CH
Immunochemistry / Allergenicity
2013:
20131104, Takahashi H
2012:
20121029, Sekiya K
2011:
20111012, Plum M
- 20110812, Nunez R
- 20110712, van Bueren JJ
- 20110609, Mariotte D
2008:
20080313, Chung CH
2005:
20051118, Riemer AB
Epidemiology
2014:
20141009, Maier S
- 20140428, Yamaguchi K
2013:
20131118, Keating K
- 20130813, Hopps S
2012:
20121116, Grandvuillemin A
- 20120213, Ishiguro M
2011:
20110803, Stevens W
2010:
20100514, George TJ Jr
2008:
20080510, Waqar SN
- 20080510, Owera R
- 20080510, Azmi SS
2007:
20070610, Allen RM
Diagnosis
2014:
20141202, Uyttebroek A
- 20141009, Maier S
- 20140808, Pacek A
- 20140804, Dupont B
- 20140612, Dupont B
- 20140428, Yamaguchi K
2013:
20131230, Michel S
- 20131104, Takahashi H
- 20131025, Ebo DG
- 20130730, Martinez-Lapiscina E
- 20130730, Fensterer H
- 20130704, Matuschek C
2012:
20121029, Sekiya K
- 20121023, Acevedo-Henao CM
- 20121018, Chakravarthy AB
- 20121010, Ito C
- 20120920, Hollander C
- 20120612, Sen S
- 20120412, Morisset M
- 20120120, Tronconi MC
... complete Reference listing ->
Immunotherapy
2009:
20091013, Saif MW
2008:
20081120, Jerath MR
- 20080510, Shah MM
2006:
20061122, Nielsen DL
Review, Editorial, Report Citations, Other Resources
2014:
20141023, Kounis G
- 20141005, Konradsen JR
- 20140915, Corominas M
- 20140723, Rispens T
- 20140718, Ju MS
- 20140714, Vultaggio A
- 20140611, van Nunen S
- 20140519, Castells Guitart MC
- 20140427, Greenberger PA
- 20140218, Leung PS
- 20140104, Berg EA
2013:
20131127, Khodarovich YM
- 20131119, Baldo BA
- 20131014, Singer J
- 20131005, Platts-Mills TA
- 20130607, Commins SP
- 20130412, Galili U
- 20130313, Barbaud A
2012:
20120918, Joerger M
- 20120910, Reichert JM
... complete Reference listing -> |
|
Loading...
)
)
)
)
)
)
)
)